chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via call center representative and described the occurrence of eye pain in a 72-year-old female patient who received SHINGRIX for prophylaxis. Concomitant products included thyroxine sodium (Levothyroxine), liothyronine sodium (Liothyronine), colestipol and oxybutynin. On 29th May 2018 14:30, the patient received the 1st dose of SHINGRIX. On 29th May 2018, several hours after receiving SHINGRIX, the patient experienced eye pain. On an unknown date, the outcome of the eye pain was unchanged. The reporter considered the eye pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that later on the evening of 29th May 2018, after vaccination with SHINGRIX in left arm, she developed eye pain that started in both eyes. The patient stated that the pain went away in the left eye by Wednesday morning, but the pain in the right eye was still present. The patient stated there was no pain in her eyes when she did not move her eyes. The patient stated that when she moved her eyes to look left and right, or up and down. She stated the pain was not excruciating. The patient had denied permission to contact their physician. The patient was referred to her physician for follow up. All questions were asked and no further details were provided.
Rash and scratching on head, arms and body. Looks like worsening eczema and swelling around left eye. No difficulty breathing. Very fussy, not sleeping at night. Eating less.
This case was reported by a physician and described the occurrence of discoloration of skin at injection site in a female subject of unspecified age who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined (Pediarix) for prophylaxis. On 29 April 2006 the subject received 2nd dose of Pediarix in the left thigh (lot AC21AC15AA). On 29 April 2006, the subject also received injections of Haemophilus influenzae type b conjugate vaccine (Prevnar) at unspecified site of administration. On an unspecified date on or after 29 April 2006 and on or before 01 May 2006, less than one week after vaccination with Pediarix, the subject experienced, "grey discoloration of pigment that is proximally up the thigh and a little bit laterally from where the injection (of Infanrix) was given". The physician stated that this is, "not ecchymosis and is very faint". The outcome of the event was not reported.
dx as acute toxic arthritic rxn to vax w/in 4 to 6 hr post vax low back pain began & progressed for next 5 to 7 days w/acute pain to low back & hips, w/fever, chills, treated in ER for severe pain;
CHILD RECEIVED VACCINE ON 06/09/09 AT PRIMARY CARE AROUND 4PM WENT HOME AND HOUR LATER ARM BECAME SORE AND HARD AND SWELLED UP APPLIED ICE AND GAVE MOTRIN 100MG, WOKE UP NEXT MORNING SWELLING REALLY WORSE MADE APPT FOR PRIMARY DR TO SEE HIM. WENT TO SEE DR (ONLY ONE AVAILIABLE TO SEE HIM) SHE SAID IT WAS JUST A REACTION AND SHOULD TAKE SOME TIME WEEKS FOR SWELLING TO GO DOWN GIVE MOTRIN 200MG FOR PAIN AND SWELLING.... RETURNED HOME THAT EVENING SWELLING WORSE BUT NOW WAS HOT TO TOUCH AND RED BLOTCHY GOING ALL THE WAY DOWN ARM INTO BACK AND NECK...TO ER, WAS TOLD IT WAS CELLULITIS FROM SHOT....FOLLOW UP CLOSLY WITH PRIMARY DR. AND WAS GIVEN PRESCRIPTION FOR KEFLEX.
Patient became nauseous shortly after receiving the vaccines (approx. 5:30pm 6/12/18). Later in the evening her arm became red, swollen, and hot to the touch. She then vomited several times between 8pm and 11pm. Was able to keep down TYLENOL later in that time frame. She slept much of 6/13/18. Was feeling better when I called on 6/14/18 approx. 11am.
Information has been received from a physician concerning a female who on an unspecified date was vaccinated with a dose of GARDASIL vaccine (yeast). On an unspecified date the patient fainted after receiving the dose of GARDASIL vaccine (yeast). The patient was seen by the physician. Patient outcome was recovered on an unspecified date. No additional information is expected.
Discouraged; Depressed; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP) for a Pfizer sponsored program.  A 87 year-old female patient received bnt162b2 (BNT162B2), administration date Sep2021 (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for Covid-19 Immunization. The following information was reported: DISCOURAGEMENT (non-serious) with onset 2021, outcome "unknown", described as "discouraged"; DEPRESSED MOOD (non-serious) with onset 2021, outcome "unknown", described as "depressed".   Additional information: Patient reports per MD instruction was off xeljanz for 7 days when had covid booster shot in Sep2021. patient agrees with the statement "generally its been hard for me to cope with rheumatoid arthritis and sometimes I feel discouraged and/or depressed".  The lot number for bnt162b2 was not provided and will be requested during follow up.
About 1:30 pm metal taste in mouth which lasted till 2 pm, then did not feel right, feel warm, shakes, face felt on fire, warm feeling in chest. Reported back to office where vaccine was administered and was taken immediately via wheel chair to the ED.
Patient received both vaccines in the right deltoid around 5:30PM at her primary care office.  On 20 December 2022.  On 21 December 2022, patient was experiencing chills and noticed around 3PM swelling and redness of her upper arm, mild discomfort.   Patient to be evaluated at Urgent Care around 6:40PM
Patient came to the pharmacy with her mother to receive her scheduled first dose of covid Pfizer vaccine. Patient seemed fine after the receiving the vaccine and once I turned around to inform the patient to stay within the premises of the pharmacy for 15 minutes, the patient fell back on the chair and seemed unconscious so her mother and I held her and I had a pharmacy tech call 911 and followed their procedure over the phone until EMS arrived to the pharmacy.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The medical history was not provided by the reporter  .  Concomitant products included MULTIVITAMINS [VITAMINS NOS] and IBUPROFEN for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not provided.   This case was linked to MOD-2021-385822, MOD-2021-385823 (Patient Link).
Received call from doctor that labs drawn on 1/27/2021 showed low filtration rate and high creatinine. Was told to report to  urgent care. Was admitted to observation unit and given IV fluids over 16 hours.  Repeated labs until improvement and discharged.  Was told cause of lab values was dehydration. I did not feel ill at any time prior to or after being notified by doctor.
Developed large lymph node (approximately 1 inch in length) in left armpit with 3 days of receiving the vaccine.  Painful at first, no longer painful.  Lump has not decreased in size.
Contracted the Delta variant two weeks ago; we were fully vaccinated with your vaccine 6 months ago/Contracted the Delta variant two weeks ago; Very sick; This is a spontaneous report from a contactable consumer. A 7-decade-old female consumer (patient) reported for herself that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: Unknown), via an unspecified route of administration on an unspecified date as dose 2, single and received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient and her husband were in their 60s and they were fully vaccinated with the vaccine 6 months ago. On unspecified dates in 2021, the patient contracted the delta variant (two weeks ago) and was very sick. The patient wanted Covid boosters to be developed and distributed as soon as possible. Also, she wanted that Pfizer should provide booster soon to help out county. The patient underwent lab tests and procedures which included sars-cov-2 test: contracted the delta variant on an unspecified date in 2021. The outcome of all events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Headache Chills Arm soreness couldn't lift arm for about 36 hours Neasea  Lack of appetite  Neck stiffness
Intense headache, chills, very tired, dizzy, was hospitalized due to epic migraine caused by vaccine booster
The patient called the pharmacy on 4/7/2021 and said that he had vomited and had been experiencing an excruciating headache that he said was worse than any headache he had ever had and was concerned about how he was feeling since he had just had his Covid vaccine on Monday.  I told him that headaches were a very common adverse reaction and that many people had experienced headaches after vaccination.  I told him that from my experience it usually didn't last more than a day for others and I assured him that it should go away soon.  I later talked to him and found out that he had went to the Emergency room that Wednesday evening (4/7/2021) because the headache was so bad.  He was seen in the ER, observed overnight, released the next morning, and then had a follow up appointment with his primary care physician on 4/15/2021.  He also had a very high blood pressure reading he told me in the Emergency room that evening he was evaluated.
FEVER, COUGH, Fatigue, Muscle or body aches, Headaches, and Congestion or runny nose
Patient mother brought patient into clinic lobby with red circular area right upper tricep measuring 1cm x 1cm and slightly raised. Area warm to touch, burns and has been there since Friday 10/22/21 few hours after receiving vaccines and got bigger over weekend. patient able to move arm without difficulty and afebrile. Encouraged patient to come for office visit to be checked and is scheduled for 10/26/21 for office visit  Gave ER precautions. Patient verbalized understanding.
vaccine brand other=Moderna/vaccine, administration date=12Nov2021, vaccine brand=Pfizer / BioNTech/vaccine, administration date=12Nov2021/Interchange of vaccine products; COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 58 years, in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 26Mar2021 as dose 1, single (Lot number: EP6955), in left arm, on 16Apr2021 as dose 2, single (Lot number: ER8721), in left arm and on 12Nov2021 as dose 3 (booster), single (Lot number: 320308D), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), as dose 4 (booster), single (Lot number: 060A22A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "COVID 19 Treatment"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "vaccine brand other=Moderna/vaccine, administration date=12Nov2021, vaccine brand=Pfizer / BioNTech/vaccine, administration date=12Nov2021/Interchange of vaccine products". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid (start date 05Oct2023, stop date 09Oct2023).  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300330560 same patient, different drug/event;
After receiving the Janssen Covid-19 Vaccine, patient stood up and got light headed and passed out. His brother caught him and guided him to the floor. Patient hit his back on the way down. The patient began to seize after being on the ground. He then got up and sat in a chair and proceeded to have another seizure.  The EMT was called and patient was evaluated. He went to the hospital to have further evaluation.
Pt reported that during the week following her vaccine the injection site got increasingly more tender and more firm. Pt was seen one week later on 11/11/19 for a follow up visit and was treated for a possible staph infection, with cephalexin 500mg. Pt was instructed to return for follow up visit but didn't show up for appointment, so outcome is unknown.
I got sick on first injection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I got sick on first injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I got sick on first injection). At the time of the report, ILLNESS (I got sick on first injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-231578 (Patient Link).
she did get an awful reaction; This is a spontaneous report from a non-contactable Other Health Care Professional. A female patient of an unspecified age (70-74 year as per raw narrative) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced she get an awful reaction on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I woke up Wednesday morning extremely dizzy and nauseous.  I was unable to open my eyes because of how dizzy I was.  I violently threw up for 2 hours .  I was carried back to my bed by my husband.  When I tried to roll over onto my side, I  threw up again.  I was unable to move on Wednesday.  I actually thought that dying was easier.  This sickness last 24 hrs.  The next day I got out of bed around 11am and still suffered mild nausea.  I am still a bit light headed today even when I woke up.
developed nausea, vomiting, and abdominal pain approximately 11 hours after vaccine injection
Information has been received from a licensed practical nurse concerning a patient who on 28-MAY-2008 was vaccinated orally with a dose of ROTATEQ. On 28-MAY-2008 the patient received an incomplete dose of ROTATEQ because the patient regurgitated during administration. No adverse event was reported. A product quality complaint was not involved. No further information is available.
has a schedule for Cortisone injection for her knee; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 16Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHROPATHY (non-serious), outcome "unknown", described as "has a schedule for Cortisone injection for her knee". Therapeutic measures were taken as a result of arthropathy.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
throbbing of my left arm; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161), via an unspecified route of administration, in left arm on 24Mar2021 10:30 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced throbbing of left arm for approximately 24 hours. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Muscle Pain (feels like muscles are ripping),  Burning throughout body (started in feet and legs and now throughout body),  lots of pain! This started on May 24th (2 weeks and 5 days after 2nd dose of vaccine), I?m still dealing with the issues and today marks 7 weeks.  I have had no relief.
Pfizer-BioNTech COVID-19 Vaccine EUA.  Baseball size rash on injection area - just a rash with heat and inching - no other irritations.  Was totally gone within three days.
13 yrs o female was given immunizations on 5/13/14 HAV#2 an HPV#2 at 12:05 pm, she returns to the clinic at 4:35 pm with a report that her eyes got swollen at 1 pm while in school/that day no other symptoms. She was given 1 dose of BENADRYL p.o. and 1 dose of prednisolone as well, She was then discharged home on ATARAX syr. P.O., follow-up 24 hrs after child was well.
BODY ACHES; TIREDNESS; This spontaneous report received from a patient concerned a 78 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-MAR-2021, the subject experienced body aches. On 14-MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and tiredness on MAR-2021. This report was non-serious. This case, from the same reporter is linked to 20210358563.
Patient called the evening of 5/14/18 complaining of severe arm pain. I called the patient on 5/16/18 to follow up with her, she reported improvement. On 5/21/18, patient was in the store and indicated that her arm still has pulsing/throbbing pain and reduced range of motion.
headache, joint & bone pain, red lump at injection site, injection site warm to the touch, soreness at injection site, some wheezing  40 x 40 mm
I became feverish with chills, nausea, sever headache and body ache that left me unable to leave my bed except to use a commode next to my bed for approximately 60 hours. After 24 hours I developed significant pain at the injection site as well as in the arm pit of the arm where I received the injection. The fever, chills, nausea, sever headache and body ache have resolved however the pain at the injection site and in the arm pit have not. A bruise has formed at the injection site . Though I have not visited a health care provider because it of it being the weekend, if the pain in my arm and in the arm pit do not subside, I will attempt to get an appointment.
Patient developed (L) arm pain and limited arm use after vaccine. She let us know today (12/29/15). No weakness or numbness, referred for Physical Therapy.
High fever for 24 hrs. Loss of taste sore throat. Headache. Extremely week. Achy
Approximately 10 minutes post-vaccination the patient described her throat being itchy and some difficulty swallowing.  She was immediately given diphenhydramine 25 mg x 1 dose and then monitored for the next 4 hours.  Her symptoms resolved quickly and had no more complaints.  She did report a previous food allergy and carries an Epi-Pen for this issue.  She did not report the specific food.
5/10/2023: Said employee contacted Employee Health late morning reporting onset of the following symptoms occurring on 5/9/2023: Nausea followed by two episodes of vomiting at 2030 & 2330. Approximately at midnight, a sensation of freezing  followed by feeling hot with reported low-grade temperature of 99.   On the mornng of the phone call (5/10/2023) stated, other symptoms included; "headache, stomach hurting  and lower back, fatifue". Denies diarrhea.   She reporte starting to drink eater and eating some bread. Dened fever at time of phone call, and, denied respiratory symptoms that may be associated with COVID-19 illness.  Advised to drink clear fluids and foods such as toast, crackers, jello. Acknowledged understanding.  5/10/2023: 1728: Update. Employoee called reporting a fever of 101 at noon, having taken Tylenol. Stated she is "feeling better". Reviewed CDC, VIS givento employee prior to administration of Tdap, correllating the potential for vaccine reaction.  Plan: Follow up with phone call on 5/11/2023.  5/11/2023: Emplyee Health, reporter of the adverse reaction contacted VAERS to review employee symptoms. It was disclosed that medical advice could not be given, but, encouraged to complete adverse reaction report.  0945: Employee Health consulted with PA regarding events. It is undetermined if this is a vaccine reaction or other illness.  1430: Consulted with Pharmacy Staff regarding event. It was discussed that in the future, when the said employee needs to be boosted that she could recieve a Td booster.
Felt like had the flu; Chills; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like had the flu), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Dec-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like had the flu), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, INFLUENZA LIKE ILLNESS (Felt like had the flu), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.            No concomitant medication were reported. No treatment information was provided by the reporter.   This case was linked to MOD-2021-406396 (Patient Link).
Slight redness on his arm 2 hours after shot.  Headache, fever, nausea and vomiting within 24 hours.